United States

(INNV Alert) Long Term Holders of InnovAge Contact Johnson Fistel for Information Regarding Investigation

SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) — Johnson Fistel, LLP is investigating potential breaches of fiduciary duty/or violations of federal and/or state law on behalf of InnovAge Holding Corp. (NASDAQ: INNV) (“InnovAge” or the “Company”) against certain of its officers and directors.

On September 21, 2021, InnovAge revealed that the Centers for Medicare and Medicaid Services (“CMS”) had “determined to freeze new enrollments at [the Company’s] Sacramento center based on deficiencies detected in [a recent] audit.” Reportedly, such “deficiencies relate to failures to provide covered services, provide accessible and adequate services, manage participants’ medical situations, and oversee use of specialists, among others.”

If you are a current, long-term shareholder of Innovage holding shares before September 21, 2021 you may have standing to hold Innovage harmless from the alleged harm caused by the Company’s officers and directors by making them personally responsible. You may also be able to assist in reforming the Company’s corporate governance to prevent future wrongdoing.

To join this action, you can click or copy and paste the link below: https://www.cognitoforms.com/JohnsonFistel/innovageholdingcorp2

Follow us on Twitter: Here

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. Johnson Fistel seeks to recover losses incurred due to violations of federal securities laws. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected] 

Disclaimer: This content is distributed by The GlobeNewswire

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Comment moderation is enabled. Your comment may take some time to appear.

Back to top button

Adblock detected

Please consider supporting us by disabling your ad blocker